Abstract
In beta therapy, β particles from 90Sr+90Y are used for the prevention and treatment of ophthalmological and dermatological diseases. For such purposes, the radiation dose is deposited by planar and concave applicators positioned on the region to be treated. Although this therapy is effective on the diseases, several complications have been reported, making these types of radioactive applicators obsolete in current clinical practice. This paper proposes a methodology to prepare and evaluate the safety of a research irradiator that re-purposes and adapts dermatologic and ophthalmic 90Sr+90Y applicators. The irradiator was constructed using low cost materials and three applicator sources. The sources are positioned at the center and the upper end of acrylic rectangular prisms. Radiochromic film was used to obtain the dose distribution on the sample holder surface. Pellets of aluminum oxide doped with carbon (Al2O3:C) were used to evaluate the reproducibility of the irradiator. The MCNPX Monte Carlo code was used for the evaluation of safety conditions. The irradiator exhibits good reproducibility of irradiation of dosimeters in pellet form and is safe to handle.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
